Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications FRONT MED-LAUSANNE
IκB kinase-α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapy EMBO J
Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors Mol Cancer
A human genome editing-based MLL::AF4 B-cell ALL model recapitulates key cellular and molecular leukemogenic features Blood
Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma Front Oncol
Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development Front Immunol
A complex interplay between H2A.Z and HP1 isoforms regulates pericentric heterochromatin Front Cell Dev Biol